Sam Kleeman, MD PhD (@KleemanSam) header
Sam Kleeman, MD PhD (@KleemanSam) profile picture

PGY1 Internal Medicine @WeillCornell. Previously: PhD/Postdoc @CSHL Janowitz/Furukawa Lab, Doctor @NHSuk, MD @UniofOxford, BA @Cambridge_Uni.

New York City, NY
Joined March 2020
Photo by Sam Kleeman, MD PhD (@KleemanSam)Photo by Sam Kleeman, MD PhD (@KleemanSam)Photo by Sam Kleeman, MD PhD (@KleemanSam)
Sam Kleeman, MD PhD retweeted
After many years of effort, deliberation, excitement, angst, joy, and Wednesday afternoon lab lunches, our group's first manuscript on cachexia, led by Venise Jan Castillon, Amy Xie, and really our whole lab nature.com/articles/s41591-0… @NatureMedicine
9
42
5
129
15,808
Sam Kleeman, MD PhD retweeted
Out now in Nature Medicine: a health-system-scale cachexia atlas (52K patients) that describes and predicts outcomes, with prospective risk models for lung, colorectal, and prostate cancer. Congrats to @EdReznik for a landmark paper for the field. nature.com/articles/s41591-0…
1
24
2
72
7,253
Sam Kleeman, MD PhD retweeted
Excited to share our new preprint: BRCA1/2 loss creates a PKM1-high metabolic state that can be therapeutically exploited. Pushing pyruvate kinase activity further with the FDA-approved drug mitapivat selectively suppresses BRCA2-deficient tumors. HRD may be more than a DNA repair defect—it may also be a targetable metabolic state. Congrats @19_maira_90 biorxiv.org/content/10.64898…
15
38
2,698
Sam Kleeman, MD PhD retweeted
Excellent summary of the NEW standard of care in Her2 positive disease. Time to abandon this one size fits all approach! #bcsm #breastcancer
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer Great review👇 ascopubs.org/doi/10.1200/JCO…
4
23
1
72
10,106
Sam Kleeman, MD PhD retweeted
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer Great review👇 ascopubs.org/doi/10.1200/JCO…
3
76
6
161
28,182
Sam Kleeman, MD PhD retweeted
Arguably the most boring step in genomics is the first one: normalization. Settled science. Scale + log. Move on. Except that here's been a huge blind spot in the field. And it matters for AIxBio. A 🧵about what I think may be one of the most important papers I've written. 1/
19
148
11
673
119,921
Sam Kleeman, MD PhD retweeted
Excited to present the first pre-print from our group, an investigation the human bone marrow microenvironments in patients with myelodysplastic syndromes (MDS) and normal age-matched subjects using Xenium genotype-informed spatial transcriptomics: biorxiv.org/content/10.64898…
6
38
4
142
13,237
Sam Kleeman, MD PhD retweeted
Autoantibodies cause autoimmune disease, shape infection outcomes, and alter cancer immunotherapy. But what role might they play in neuropsychiatric disease? In our new preprint, Katlyn Nemani and @JillianRJaycox take on this question in schizophrenia. 🧵 biorxiv.org/content/10.64898…
14
57
7
207
32,073
Register today for the next @WCMEnglanderIPM #PrecisionMedicine Research Conference, featuring Drs. Sam Oscar Kleeman (@KleemanSam) from @CSHL and Vered Stearns (@VeredStearns) from Weill Cornell Medicine! #BreastCancer #Biomarkers
1
3
1
9
2,014
Immune surveillance can be a double-edged sword. ⚔️ In @Nature, Endeavor Awardee @JanowitzTobias shows that the same B cell response targeting NMDAR-expressing breast cancer tumors can mature into antibodies that trigger autoimmune disease. nature.com/articles/s41586-0…
7
25
1,764
Sam Kleeman, MD PhD retweeted
Pleased to share our new collaborative work on the link between anti-cancer immunity and anti-NMDAR encephalitis. Clinical sample, mouse model, BCR seq, cryo-EM, electrophysiology, behavior, etc. @JanowitzTobias @KleemanSam and more. nature.com/articles/s41586-0…
1
3
238
Our new paper in @TheLancetPsych NMDAR-antibody is very different from most forms of psychosis. - Rapid Onset - Complex, Polysymptomatic features - Often starts with mood - Dynamic over a short timescale - plus some more specific characteristics url-shortener.me/2XKW
4
26
1
95
9,202
Sam Kleeman, MD PhD retweeted
Where do cancers start? In the liver, not all cells are the same. The liver is divided into 3 “zones,” and each specializes in different metabolic tasks. We show in @Science that where a mutation occurs in a liver lobule can determine a cell’s fate. science.org/doi/10.1126/scie… (1/9)
23
136
9
494
72,829
Sam Kleeman, MD PhD retweeted
Proud to share @niseto’s (new PI @TheCrick) paper: As a postdoc (@CSHL/@HopkinsMedicine), he found #NETs in necrotic tumors—I shrugged. But he looked closer: NETs block tumor vessel perfusion, causing necrosis, hypoxia, EMT & #Metastasis. nature.com/articles/s41586-0… @JHU_BDP @Nature
17
62
5
226
19,469
Sam Kleeman, MD PhD retweeted
🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in @NatureGenet 🧬! shorturl.at/94s5S We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n 🧵👇
21
44
6
131
21,262